1. Home
  2. BMRN
  3. BMRN News

Latest BioMarin Pharmaceutical Inc. (BMRN) News on January 23, 2025

Nanobiotix Stock Gains as Dosing Begins in Mid-Stage NSCLC Study
BMRN

Zacks

2 days ago

Nanobiotix Stock Gains as Dosing Begins in Mid-Stage NSCLC Study

Earnings are growing at BioMarin Pharmaceutical (NASDAQ:BMRN) but shareholders still don't like its prospects
BMRN

Simply Wall St.

2 days ago

Earnings are growing at BioMarin Pharmaceutical (NASDAQ:BMRN) but shareholders still don't like its prospects

BioMarin Pharmaceutical Inc. (BMRN) Stock: The Under-the-Radar Stock Poised for Massive Upside in 2025
BMRN

Insider Monkey

2 days ago

BioMarin Pharmaceutical Inc. (BMRN) Stock: The Under-the-Radar Stock Poised for Massive Upside in 2025

Here is Why Growth Investors Should Buy BioMarin (BMRN) Now
BMRN

Zacks

3 days ago

Here is Why Growth Investors Should Buy BioMarin (BMRN) Now

Zacks Industry Outlook Highlights Incyte, BioMarin, Exelixis, Halozyme and Blueprint Medicines
BMRN

Zacks

8 days ago

Zacks Industry Outlook Highlights Incyte, BioMarin, Exelixis, Halozyme and Blueprint Medicines

BMRN

Argus Research

8 days ago

BMRN: Lowering target price to $51.00

5 Biotech Stocks Worth Adding to Your Portfolio in 2025
BMRN

Zacks

9 days ago

5 Biotech Stocks Worth Adding to Your Portfolio in 2025

BMRN

MT Newswires

10 days ago

BioMarin Pharmaceutical Sues Ascendis Pharma for Alleged Patent Infringement in Germany

BioMarin Announces Legal Action Against Ascendis Pharma A/S in European Unified Patent Court
BMRN

PR Newswire

10 days ago

BioMarin Announces Legal Action Against Ascendis Pharma A/S in European Unified Patent Court

Wall Street Analysts Predict a 45.86% Upside in BioMarin (BMRN): Here's What You Should Know
BMRN

Zacks

10 days ago

Wall Street Analysts Predict a 45.86% Upside in BioMarin (BMRN): Here's What You Should Know

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock
BMRN

Zacks

10 days ago

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
BMRN

Zacks

13 days ago

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
BMRN

Zacks

14 days ago

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

Zacks.com featured highlights include Leidos, Amazon.com, Halozyme Therapeutics and BioMarin Pharmaceutical
BMRN

Zacks

16 days ago

Zacks.com featured highlights include Leidos, Amazon.com, Halozyme Therapeutics and BioMarin Pharmaceutical

These 4 Stocks Boast Impressive Interest Coverage Ratios
BMRN

Zacks

17 days ago

These 4 Stocks Boast Impressive Interest Coverage Ratios

BioMarin to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, at 9:00 am PT / 12:00 pm ET, in San Francisco, CA
BMRN

PR Newswire

17 days ago

BioMarin to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, at 9:00 am PT / 12:00 pm ET, in San Francisco, CA

10 Magnificent Stocks That Can Make You Richer in 2025
BMRN

Motley Fool

20 days ago

10 Magnificent Stocks That Can Make You Richer in 2025

3 Reasons Why Growth Investors Shouldn't Overlook BioMarin (BMRN)
BMRN

Zacks

21 days ago

3 Reasons Why Growth Investors Shouldn't Overlook BioMarin (BMRN)

BMRN or TECH: Which Is the Better Value Stock Right Now?
BMRN

Zacks

21 days ago

BMRN or TECH: Which Is the Better Value Stock Right Now?

Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term
BMRN

Zacks

a month ago

Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term

Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term
BMRN

Zacks

a month ago

Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term

BMRN

Argus Research

a month ago

BMRN: Lowering target price to $53.00

Is the Options Market Predicting a Spike in BioMarin Pharmaceutical (BMRN) Stock?
BMRN

Zacks

a month ago

Is the Options Market Predicting a Spike in BioMarin Pharmaceutical (BMRN) Stock?

BMRN

Argus Research

a month ago

BMRN: Rating decreased to a SELL

BioMarin Pharmaceutical (BMRN) is a Top-Ranked Momentum Stock: Should You Buy?
BMRN

Zacks

a month ago

BioMarin Pharmaceutical (BMRN) is a Top-Ranked Momentum Stock: Should You Buy?

Are BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
BMRN

Simply Wall St.

a month ago

Are BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?

BMRN

Argus Research

a month ago

BMRN: Raising target price to $70.00

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
BMRN

Zacks

a month ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

BMRN

Morningstar Research

a month ago

Analyst Report: BioMarin Pharmaceutical Inc.

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
BMRN

Zacks

2 months ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Why Is Beam Therapeutics (BEAM) Down 2.3% Since Last Earnings Report?
BMRN

Zacks

2 months ago

Why Is Beam Therapeutics (BEAM) Down 2.3% Since Last Earnings Report?

BMRN

Argus Research

2 months ago

BMRN: Lowering target price to $66.00

Why Is BioMarin (BMRN) Down 1.9% Since Last Earnings Report?
BMRN

Zacks

2 months ago

Why Is BioMarin (BMRN) Down 1.9% Since Last Earnings Report?

Why Is BioMarin Pharmaceutical Inc. (BMRN) Among the Worst Performing Healthcare Stocks in 2024?
BMRN

Insider Monkey

2 months ago

Why Is BioMarin Pharmaceutical Inc. (BMRN) Among the Worst Performing Healthcare Stocks in 2024?

BMRN

Argus Research

2 months ago

BMRN: Raising target price to $68.00

BMRN

MT Newswires

2 months ago

RBC Cuts Price Target on BioMarin Pharmaceutical to $70 From $80, Keeps Sector Perform Rating

Why Is BioMarin Pharmaceutical Inc. (BMRN) Among the Worst Performing Biotech Stocks in 2024?
BMRN

Insider Monkey

2 months ago

Why Is BioMarin Pharmaceutical Inc. (BMRN) Among the Worst Performing Biotech Stocks in 2024?

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock
BMRN

Zacks

2 months ago

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
BMRN

Zacks

2 months ago

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

BioMarin Pharmaceutical Inc. (BMRN): Among the Best Genomics Stocks to Buy Right Now
BMRN

Insider Monkey

2 months ago

BioMarin Pharmaceutical Inc. (BMRN): Among the Best Genomics Stocks to Buy Right Now

BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024
BMRN

PR Newswire

2 months ago

BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024

BMRN

MT Newswires

2 months ago

Wolfe Research Initiates BioMarin Pharmaceutical at Outperform With $95 Price Target

BMRN

MT Newswires

2 months ago

Biomarin Pharmaceutical Insider Sold Shares Worth $350,324, According to a Recent SEC Filing

BMRN

Argus Research

2 months ago

BMRN: What does Argus have to say about BMRN?

Implied Volatility Surging for BioMarin Pharmaceutical (BMRN) Stock Options
BMRN

Zacks

2 months ago

Implied Volatility Surging for BioMarin Pharmaceutical (BMRN) Stock Options

Here’s Why BioMarin Aristotle Large Cap Growth Strategy Divested From Pharmaceutical (BMRN)
BMRN

Insider Monkey

3 months ago

Here’s Why BioMarin Aristotle Large Cap Growth Strategy Divested From Pharmaceutical (BMRN)

BioMarin to Participate in Three Upcoming Investor Conferences
BMRN

PR Newswire

3 months ago

BioMarin to Participate in Three Upcoming Investor Conferences

BMRN

Argus Research

3 months ago

BMRN: Lowering target price to $69.00

Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term
BMRN

Zacks

3 months ago

Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term

Is BioMarin (BMRN) a Solid Growth Stock? 3 Reasons to Think "Yes"
BMRN

Zacks

3 months ago

Is BioMarin (BMRN) a Solid Growth Stock? 3 Reasons to Think "Yes"

BioMarin (BMRN) Upgraded to Buy: Here's Why
BMRN

Zacks

3 months ago

BioMarin (BMRN) Upgraded to Buy: Here's Why

BMRN vs. INCY: Which Stock Is the Better Value Option?
BMRN

Zacks

3 months ago

BMRN vs. INCY: Which Stock Is the Better Value Option?

Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term
BMRN

Zacks

3 months ago

Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term

Beyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc (BMRN)
BMRN

GuruFocus.com

3 months ago

Beyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc (BMRN)

BioMarin price target raised to $106 from $104 at UBS
BMRN

TipRanks

3 months ago

BioMarin price target raised to $106 from $104 at UBS

BioMarin Pharmaceutical Third Quarter 2024 Earnings: Beats Expectations
BMRN

Simply Wall St.

3 months ago

BioMarin Pharmaceutical Third Quarter 2024 Earnings: Beats Expectations

BMRN

Thomson Reuters StreetEvents

3 months ago

Q3 2024 BioMarin Pharmaceutical Inc Earnings Call

BioMarin Q3 Earnings & Revenues Beat Estimates, '24 Guidance Raised
BMRN

Zacks

3 months ago

BioMarin Q3 Earnings & Revenues Beat Estimates, '24 Guidance Raised

BMRN

MT Newswires

3 months ago

UBS Adjusts Price Target on BioMarin Pharmaceutical to $106 From $104, Maintains Buy Rating

BMRN

Morningstar Research

3 months ago

Analyst Report: BioMarin Pharmaceutical Inc.

Biomarin Pharmaceutical Inc (BMRN) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...
BMRN

GuruFocus.com

3 months ago

Biomarin Pharmaceutical Inc (BMRN) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

BioMarin (BMRN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
BMRN

Zacks

3 months ago

BioMarin (BMRN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

BioMarin Pharmaceutical (BMRN) Tops Q3 Earnings and Revenue Estimates
BMRN

Zacks

3 months ago

BioMarin Pharmaceutical (BMRN) Tops Q3 Earnings and Revenue Estimates

BMRN

MT Newswires

3 months ago

BioMarin Pharmaceutical Q3 Non-GAAP Earnings, Revenue Rise; 2024 Forecast Boosted

BMRN

Associated Press Finance

3 months ago

BioMarin: Q3 Earnings Snapshot

BioMarin Announces 28% Y/Y Total Revenue Growth in the Third Quarter and Increase in Full-year 2024 Guidance; Reaffirms Long-term Guidance and Outlook
BMRN

PR Newswire

3 months ago

BioMarin Announces 28% Y/Y Total Revenue Growth in the Third Quarter and Increase in Full-year 2024 Guidance; Reaffirms Long-term Guidance and Outlook

Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate
BMRN

GlobeNewswire

3 months ago

Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate

BioMarin Pharmaceutical (BMRN): Hedge Funds Back Biotech Leader Amid Record Revenue Growth
BMRN

Insider Monkey

3 months ago

BioMarin Pharmaceutical (BMRN): Hedge Funds Back Biotech Leader Amid Record Revenue Growth

Blueprint Medicines (BPMC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
BMRN

Zacks

3 months ago

Blueprint Medicines (BPMC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
BMRN

Zacks

3 months ago

BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
BMRN

Zacks

3 months ago

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ET
BMRN

PR Newswire

3 months ago

BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ET

BMRN

Argus Research

3 months ago

BMRN: Lowering target price to $72.00

Do Options Traders Know Something About BioMarin (BMRN) Stock We Don't?
BMRN

Zacks

4 months ago

Do Options Traders Know Something About BioMarin (BMRN) Stock We Don't?

BMRN

MT Newswires

4 months ago

RBC Lowers Price Target on BioMarin Pharmaceutical to $80 From $85, Keeps Sector Perform Rating

3 Reasons Why Growth Investors Shouldn't Overlook BioMarin (BMRN)
BMRN

Zacks

4 months ago

3 Reasons Why Growth Investors Shouldn't Overlook BioMarin (BMRN)

BMRN or MYGN: Which Is the Better Value Stock Right Now?
BMRN

Zacks

4 months ago

BMRN or MYGN: Which Is the Better Value Stock Right Now?

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
BMRN

Zacks

4 months ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Down -22.94% in 4 Weeks, Here's Why You Should You Buy the Dip in BioMarin (BMRN)
BMRN

Zacks

4 months ago

Down -22.94% in 4 Weeks, Here's Why You Should You Buy the Dip in BioMarin (BMRN)

Andreas Halvorsen's Firm Expands Grip in BioMarin Pharmaceutical Inc Holding
BMRN

GuruFocus.com

4 months ago

Andreas Halvorsen's Firm Expands Grip in BioMarin Pharmaceutical Inc Holding

Andreas Halvorsen's Strategic Acquisition in BioMarin Pharmaceutical Inc
BMRN

GuruFocus.com

4 months ago

Andreas Halvorsen's Strategic Acquisition in BioMarin Pharmaceutical Inc

Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term
BMRN

Zacks

4 months ago

Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term

High Growth Tech Stocks To Watch For Future Potential
BMRN

Simply Wall St.

4 months ago

High Growth Tech Stocks To Watch For Future Potential

BioMarin Stands Firm on 2027 Revenue Target Amid Ascendis Competition, Goldman Sachs Analyst Remains Bullish
BMRN

Benzinga

4 months ago

BioMarin Stands Firm on 2027 Revenue Target Amid Ascendis Competition, Goldman Sachs Analyst Remains Bullish

BioMarin (BMRN): Strong Results and ROCTAVIAN Progress Make It a Mid-Cap Growth Gem
BMRN

Insider Monkey

4 months ago

BioMarin (BMRN): Strong Results and ROCTAVIAN Progress Make It a Mid-Cap Growth Gem

BioMarin to Present Data Underscoring Sustained Positive Impact of VOXZOGO® (vosoritide) on Health-Related Quality of Life, Growth and Maintenance of Bone Strength in Children with Achondroplasia at 2024 International Skeletal Dysplasia Society Meeting
BMRN

PR Newswire

4 months ago

BioMarin to Present Data Underscoring Sustained Positive Impact of VOXZOGO® (vosoritide) on Health-Related Quality of Life, Growth and Maintenance of Bone Strength in Children with Achondroplasia at 2024 International Skeletal Dysplasia Society Meeting

Ascendis Soars on Encouraging Data From Dwarfism Drug Study
BMRN

Zacks

4 months ago

Ascendis Soars on Encouraging Data From Dwarfism Drug Study

BMRN

Morningstar Research

4 months ago

Analyst Report: BioMarin Pharmaceutical Inc.

BMRN

MT Newswires

4 months ago

Truist Cuts Price Target on BioMarin Pharmaceutical to $90 From $118, Keeps Buy Rating

Ascendis trial data piles pressure on BioMarin
BMRN

BioPharma Dive

4 months ago

Ascendis trial data piles pressure on BioMarin

BMRN

MT Newswires

4 months ago

RBC Cuts Price Target on BioMarin Pharmaceutical to $85 From $100, Keeps Sector Perform Rating

BMRN

Morningstar Research

4 months ago

Analyst Report: BioMarin Pharmaceutical Inc.

Ascendis Rockets — And Hammers BioMarin — On New Results For Growth Drug
BMRN

Investor's Business Daily

4 months ago

Ascendis Rockets — And Hammers BioMarin — On New Results For Growth Drug

Despite Being First Mover, BioMarin's Voxzogo For Dwarfism To Face Pressure From Ascendis' Candidate In Near Term
BMRN

Benzinga

4 months ago

Despite Being First Mover, BioMarin's Voxzogo For Dwarfism To Face Pressure From Ascendis' Candidate In Near Term

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
BMRN

Zacks

4 months ago

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

BioMarin Pharmaceutical Inc. (BMRN): Is This Biotech Stock A Good Buy?
BMRN

Insider Monkey

4 months ago

BioMarin Pharmaceutical Inc. (BMRN): Is This Biotech Stock A Good Buy?

BioMarin Posts '27 Biz View, Outlines Growth Plans for Next 10 Years
BMRN

Zacks

5 months ago

BioMarin Posts '27 Biz View, Outlines Growth Plans for Next 10 Years

BMRN

MT Newswires

5 months ago

Truist Securities Adjusts Price Target on BioMarin Pharmaceutical to $118 From $140, Maintains Buy Rating

BioMarin, having retrenched, outlines plans for growth
BMRN

BioPharma Dive

5 months ago

BioMarin, having retrenched, outlines plans for growth

BioMarin Holds Investor Day; Provides New Corporate Strategy and Introduces 2027 Financial Guidance
BMRN

PR Newswire

5 months ago

BioMarin Holds Investor Day; Provides New Corporate Strategy and Introduces 2027 Financial Guidance

Share on Social Networks: